HIV Vaccine In Early Trials

A new vaccine approach to HIV that stimulates a set of rare immune cells showed 97% success at targeting those cells in its first tests in humans. For more on the vaccine: https://www.livescience.com/early-hiv-vaccine-trial-results.html

Science News • Videos • Explainers
SUBSCRIBE to the Live Science YouTube channel → https://www.youtube.com/channel/UCOTA1_oiKnz8po1Rm3nDJPg?sub_confirmation=1
Twitter→ https://twitter.com/LiveScience
Facebook→ https://www.facebook.com/livescience
Instagram→ https://www.instagram.com/live_science/
Community Forums→ https://forums.livescience.com/

For the science geek in everyone, LiveScience.com breaks down the stories behind the most interesting news and photos on the Internet, while also digging up fascinating discoveries that hit on a broad range of fields, from dinosaurs and archaeology to wacky physics and astronomy to health and human history. If you want to learn something interesting every day, #LiveScience is the place for you. #HIV #HIVvaccine

Видео HIV Vaccine In Early Trials канала LiveScience